Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Darbepoetin Alfa for the Treatment of Anemia of Cancer

This study has been completed.
Information provided by (Responsible Party):
Amgen Identifier:
First received: September 17, 2004
Last updated: May 6, 2013
Last verified: May 2013